Examining CD103 + Tissue‐Resident Memory T Cells in Nasopharyngeal Carcinoma
Head & Neck · 2026
DOI: 10.1002/hed.70026 ↗At a glance
Journal article in Head & Neck, 2026. Written by Alesha A Thai and 9 co-authors. Institution: Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Major MEDLINE topics: Integrin alpha Chains, Antigens, CD, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms. 70 references. Funded by: Peter MacCallum Foundation, Hong Kong SAR Research Grant Council, National Medical Research Council Singapore Clinician Scientist Award.
Abstract (original language)
Background
Tissue‐resident memory T cells (T RMs ), identified by CD103 expression, play key roles in infection and cancer and often correlate with improved survival in the latter. Their characterization in nasopharyngeal carcinoma (NPC) is of interest due to its viral etiology.
Methods
NPC tumors from patients treated at Peter MacCallum Cancer Centre (PMCC; 2000–2017) were examined for CD103 + , CD8 + T cells, and PD‐L1 abundance, correlated with survival, and underwent NanoString transcriptomic analysis. Additional cohorts from Hong Kong and Singapore were assessed for CD103 + intra‐tumoral immune cell (ITIC) abundance.
Results
Of the 141 PMCC patients, 29% ( n = 30/103) of NPC tumors had high CD103 + ITIC (defined as ≥ 30%) linked with T RM gene expression, immune checkpoints, and upregulated pathways in T‐cell activation. Abundance of CD103 + ITIC was not associated with improved survival (PMCC: HR = 0.9, 95% CI: 0.4–2.1) across all cohorts.
Conclusions
Despite similarities to other virally driven tumors, CD103 + ITIC abundance was not prognostic in NPC, highlighting the need for better characterization of T RMs subpopulations.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
- Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Department of Clinical Oncology, The Chinese University of Hong Kong Special Administrative Region, Hong Kong.
- Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.
Funding
- Peter MacCallum Foundation
- Hong Kong SAR Research Grant Council
- National Medical Research Council Singapore Clinician Scientist Award
- Duke-NUS Oncology Academic Program Goh Foundation Proton Research Program
- Kua Hong Pak Head and Neck Cancer Research Program
Cite
APA
Thai, A. A., Young, R. J., Bressel, M., Ma, B. B. Y., Chua, M. L. K., Soni, P., Angel, C., Trigos, A., Rischin, D., & Solomon, B. J. (2026). Examining CD103 + Tissue‐Resident Memory T Cells in Nasopharyngeal Carcinoma. Head & Neck. https://doi.org/10.1002/hed.70026
Vancouver
Thai AA, Young RJ, Bressel M, Ma BBY, Chua MLK, Soni P, et al. Examining CD103 + Tissue‐Resident Memory T Cells in Nasopharyngeal Carcinoma. Head & Neck. 2026. doi:10.1002/hed.70026
BibTeX
@article{Thai2026,
author = {Thai, Alesha A and Young, Richard J and Bressel, Mathias and Ma, Brigitte B Y and Chua, Melvin L K and Soni, Pinki and Angel, Christopher and Trigos, Anna and Rischin, Danny and Solomon, Benjamin J},
title = {Examining CD103 + Tissue‐Resident Memory T Cells in Nasopharyngeal Carcinoma},
journal = {Head & Neck},
year = {2026},
doi = {10.1002/hed.70026}
}
EUVIMED